There are still 2,026,065 active cases in the country, as there was a decrease of 88,416 cases in the past 24 hours.
The B.1.617.1 and B.1.617.2 variants of the COVID-19, first identified in India, have been named as "Kappa" and "Delta" respectively, the World Health Organisation (WHO) announced on Monday as it named various variants of the coronavirus using Greek alphabets.
As per the health agency, all the variants of the COVID-19 virus have been named in Greek letters.
India registered record fatalities due to Covid on May 21 with 4,529 deaths - the highest from Covid infection in any country in a day since the coronavirus outbreak was reported in China's Wuhan in December 2019. "The export of Amphotericin-B injections... is restricted, with immediate effect", it said. "We're not saying replace B.1.1.7, but really just to try to help some of the dialogue with the average person", she told US-based website STAT.
This is for the third time since April 13 that India has recorded less than two lakh cases of Covid. A 11-year-old girl from Ballari district and 14-year-old boy from Chitradurga district have been infected with the fungal disease.
Could covid-19 have originated in a copper mine?
He also warned that uncertainty may persist, noting that the origin of the 2014 Ebola outbreak still isn't fully understood. Facebook will no longer remove posts claiming the coronavirus is "man-made", it said Wednesday.
Bihar, Uttarakhand and Chhattisgarh on Monday extended COVID-induced lockdown or curfew though there will be some relaxation in curbs. At Apollo, an official said, only about 180 Covid beds were occupied.
Despite relaxations, night curfew and weekend shutdown will remain in force in some states and UTs. So far, 53.53 lakh people have been inoculated, including over 12 lakh, who have received both the doses, the health bulletin said.
In another positive development, Serum Institute of India (SII) on Sunday said it will be able to manufacture and supply 9-10 crore doses of Covishield in June, which will provide a big boost to the ongoing vaccination drive in India when several states are complaining of a vaccine shortage.
Most of the shots administered in India are AstraZeneca, but local firm Bharat Biotech also plans to ramp up production of its Covaxin vaccine to 23 million in June from about 10 million in April, a government official said.